Skip to main content
Caplight Logo









Microbion Corporation

Microbion Corporation

Private
Bozeman, MontanaHealthcare & Life Scienceshttps://microbioncorp.com/

Last Round

Grant

Jun 7, 2022

Total Funding Raised

$55.08M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Microbion Corporation is a clinical-stage pharmaceutical company that develops a novel class of compounds for the treatment of difficult-to-treat infections, including chronic and antibiotic-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

antibiotic resistancepravibismanesuperbugsbiofilm eradicationanti-infective drugsanti-biofilmdiabetic foot ulcer treatmentorthopedic implant infectionclinical-stage pharmachronic infection treatmentfirst-in-class drugdrug-resistant pathogenscystic fibrosis infectionnon-tuberculous mycobacteriaNTM infectionnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Microbion Corporation Comparables

Compare Microbion Corporation with similar companies based on industry and business-model similarity.

Microbion Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Recce Pharmaceuticals Ltd
83%
NovaBiotics Ltd
79%
BiomX Inc.
78%

Microbion Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 7, 2022
VC RoundAug 20, 2021
VC RoundMar 1, 2021
GrantFeb 22, 2021
StrategicJan 12, 2021
Grant
May 28, 2020

Microbion Corporation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 272% MoM, reaching 2.5K.

  • Nov 7, 2025

    Monthly visitors increased 239% MoM.

Microbion Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Microbion Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Microbion Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersBozeman, Montana
Employee Range13
Year Founded2000
Last FundingJun 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?